Latest News:

ar deelen fr it

TIF

FAiTh – Fight Against Thalassemia Activities report 2018-19

The »FAiTh- Fight Against Thalassemia» patients & parents Association just published thei...
TIF Preceptorship Programme 2019

...
34 year old Victoria Gray will be the first American to get controversial gene-editing treatment for sickle cell disease

Victoria Gray, 34-year-old mother-of-four, has volunteered to be the first American to have t...
World Hepatitis Day 2019

World Hepatitis Day (WHD) takes places every year on 28 July bringing the world together under a sin...
FDA Accelerates Review Of Sickle Cell Disease Medicine Crizanlizumab

Novartis announced earlier today the FDA accepted the company’s Biologics License Application ...

Highlights

TIF e-AcademyAcadémie électronique de la FITe-Academyالأكاديمية الإلكترونية للاتحاد الدولي للثلاسيمياΗλεκτρονική ΑκαδημίαTIF e-Akademie

Patients' StoriesRécits de patientsStorie di pazientiقصص المرضىΙστορίες ΑσθενώνErfahrungsberichte von Patienten

Clinical Trial UpdatesEssais cliniques - Mises à jourAggiornamenti sugli studi cliniciآخر مستجدات التجارب الإكلينكية Ενημερώσεις για κλινικές δοκιμέςUpdate zu klinischen Studien

Renzo Galanello FellowshipsBourses Renzo GalanelloBorsa di studio Renzo Galanelloمنحة رينزو جالانيلوΥποτροφίες Renzo GalanelloRenzo Galanello Stipendien

International Thalassaemia DayJournée Mondiale de la ThalassémieGiornata internazionale della talassemiaاليوم العالمي ’للثلاسيميا’Παγκόσμια Ημέρα ΘαλασσαιμίαςInternationaler Tag der Thalassämie

The THALIA ProjectThe THALIA ProjectThe THALIA ProjectThe THALIA ProjectThe THALIA ProjectThe THALIA Project

A review article published in Blood, summarizes the current literature on the challenges of chronic #blood… https://t.co/26XsyCFtzl 09/08/2019
Findings of new research from a clinical trial co-led by Imperial College London and UCL suggest that giving larger… https://t.co/ueMUgM1qLg 08/08/2019
1 blood donation can potentially save up to 3 lives! This summer before you go on vacation, please remember to mak… https://t.co/WUVDDyK2cb 07/08/2019
The Phase 3 RESET trial testing the effectiveness and safety of Rivipansel, Pfizer‘s investigational candidate to t… https://t.co/aWpQKOGm8Y 06/08/2019

Supporters Sympathisants Sostenitori الداعمون Οι Υποστηρικτές μας Unterstützer